about
Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcomaOsteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesMammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomicsDifferentiation and transdifferentiation potentials of cancer stem cellsAldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and TreatmentSynovial sarcoma: recent discoveries as a roadmap to new avenues for therapyHDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial SarcomaSS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic ModifierTherapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma.Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2.Notch signaling in pediatric soft tissue sarcomasMesenchymal stem cell transformation and sarcoma genesis.The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling.A novel angiomatoid epithelioid sarcoma cell line, Asra-EPS, forming tumors with large cysts containing hemorrhagic fluid in vivo.Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.Deflection of vascular endothelial growth factor action by SS18-SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcomaCancer/testis (CT) antigens, carcinogenesis and spermatogenesis.Advances in sarcoma genomics and new therapeutic targets.Synovial sarcoma of the buttocks presenting with a non-healing wound and rapid progression after local resection: a case report.A primary intravascular synovial sarcoma causing deep-vein thrombosis and pulmonary embolism in a 20-year-old woman.Formation of spherical cancer stem-like cell colonies with resistance to chemotherapy drugs in the human malignant fibrous histiocytoma NMFH-1 cell lineβ-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition.Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.50 years ago in CORR: Synovial sarcoma. Kirk J. Anderson, MD and Orliss Wildermuth, MD CORR 1961;29:55-70Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitroThe role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation.Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.Modeling sarcomagenesis using multipotent mesenchymal stem cells.The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer.Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications.Targeting the Wnt pathway in synovial sarcoma models.Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2.The influential role of BCL2 family members in synovial sarcomagenesis.Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy.Primary Intracranial Synovial SarcomaPatient-derived osteosarcoma cells are resistant to methotrexate.
P2860
Q24337483-81074D7D-BF63-4034-A97A-D0376FAB280CQ26745742-479235AB-6362-4E1B-8BAD-C1BE1AFF5757Q26776098-BACAEF09-0AA8-46CC-A500-084CEC35CB9AQ26782242-9B2D1E72-7DCD-4B60-8A29-FC6F5FA5378EQ27342050-6E9CFB45-CD0A-45F9-91ED-FCC0F8BD30CAQ28076462-2786A74B-8744-47D6-96D5-8972785C6E70Q28087134-0F73EBF5-3FF8-4880-AE56-54C6CB664E0AQ28468451-80689824-E9AD-40B3-AA7F-C7F4A687635EQ28550973-1440B5F2-5471-4B81-8B91-2D37DED8CFD9Q33696791-745E3F45-9C6E-466D-BCA1-6495E5A49CE2Q33826472-E3946295-F3B1-44D5-A07E-8CDAC56F9CFCQ34272305-32718639-DD8A-49CF-AFD5-915C383327E0Q34480012-B89D5261-2273-4F71-8B1C-A3722732E49EQ34654560-F40C93AA-A3D7-43E7-BA70-2573A8282106Q34657445-8D7A5C0A-E8BB-40AE-9C8C-B67E7791B3CFQ34895354-A968DD80-38B4-40F6-B7D0-740C6C9671B7Q35018901-E2B6BFC2-9387-43E7-B2D0-9BD6EE2B58CFQ35713658-9E5ED52C-3136-46FF-82A9-12245238CC9FQ35733359-24AC9E59-D866-47F0-BBA7-8CD481A67620Q35993346-34C418F3-046C-4A0E-B96A-3809131AE5E5Q36138830-0693BC98-8482-4568-86D9-DC10E05DBBA5Q36169914-748DE9AB-5E79-4B69-B581-C25AD8FB98CFQ36334761-849DC317-566C-4BE9-8AF1-5338E4199CC8Q36356064-A94B0699-EF9B-4E00-9D46-357D947F24A3Q36388149-97431DDF-9116-40B2-80AA-93F0466D2AC4Q36584337-9D27FA85-2221-4206-986E-CD35D92AD5F6Q36586014-75DBD63A-8766-413F-A641-17D30F50610BQ36850467-F8B40B80-496B-4677-B76A-7AE8A607669BQ37043780-832FFCC1-102D-4B6D-BD5D-EE058385C036Q37500347-A71D62BA-BC33-43A1-BD5D-1AEAA9106513Q37544362-876C199B-EFB2-4218-B3E6-A30DB185F23AQ37935534-4032AF77-5327-4003-8272-1E30A65FBF86Q38896059-E81C2855-30D5-458B-B4BD-029880BAB21FQ39026978-E7254B35-56A5-4537-80E1-270B8EF5C9C6Q39114461-CF6B2E48-C64B-403D-AE10-65515D605AA8Q39458600-D4DC58D6-A504-4A6B-BE44-8ED27B7A5C6FQ40066050-62B72F6D-7F72-4A72-81E0-3757B12616B2Q41918438-C2ECCCE8-0FC6-4482-937F-F9D4D9378FC3Q42201556-5EFA8AFB-B84D-46A8-8FC9-23960DAB23C0Q42362093-F8C5A8F5-3A2D-4AC0-B7C4-F2560BC6AB10
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Synovial sarcoma is a stem cell malignancy.
@en
Synovial sarcoma is a stem cell malignancy.
@nl
type
label
Synovial sarcoma is a stem cell malignancy.
@en
Synovial sarcoma is a stem cell malignancy.
@nl
prefLabel
Synovial sarcoma is a stem cell malignancy.
@en
Synovial sarcoma is a stem cell malignancy.
@nl
P2093
P356
P1433
P1476
Synovial sarcoma is a stem cell malignancy
@en
P2093
Hideki Yoshikawa
Ken-Ichiro Hamada
Kiyoko Yoshioka
Nobuhito Araki
Nobuyuki Hashimoto
Norifumi Naka
Satoshi Takenaka
Susumu Joyama
Takafumi Ueda
Toshitada Miwa
P304
P356
10.1002/STEM.452
P577
2010-07-01T00:00:00Z